{
    "title": "Sanofi's Dupixent gets U.S. approval to treat eczema in young children",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10894533/Sanofis-Dupixent-gets-U-S-approval-treat-eczema-young-children.html",
    "date": "2022-06-07",
    "keywords": [
        "dupixent",
        "drug",
        "eczema",
        "sanofi",
        "regeneron",
        "product",
        "atopic",
        "dermatitis",
        "inflammation",
        "skin",
        "june",
        "food",
        "administration",
        "use",
        "treatment",
        "share",
        "profit",
        "loss",
        "approval",
        "latestage",
        "study",
        "clearance",
        "severity",
        "inflammationcausing",
        "il4",
        "bodys",
        "response",
        "number",
        "revenue",
        "companys",
        "range",
        "adult",
        "asthma",
        "condition",
        "irritation",
        "population",
        "institute",
        "allergy",
        "reporting",
        "bhanvi",
        "satija",
        "leo",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}